Resmed Inc. buy Royal Bank of Canada
Start price
15:02
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-4.22%
Price
16:30
€213.10
Summary
This prediction is currently active. With a performance of -4.22%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 30.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | -4.22% |
| iShares Core DAX® | -1.410% |
| iShares Nasdaq 100 | -0.450% |
| iShares Nikkei 225® | -0.224% |
| iShares S&P 500 | -1.095% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for RMD provided by MarketBeat